XML 21 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Financial Information
3 Months Ended
Mar. 31, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Note 1 – Basis of Presentation and Description of Business
 
Basis of Presentation
As used in these Notes to Condensed Consolidated
 
Financial Statements, the terms “Quaker”, “Quaker Houghton”,
 
the
“Company”, “we”, and “our” refer to Quaker Chemical
 
Corporation (doing business as Quaker Houghton), its subsidiaries, and
associated companies, unless the context otherwise requires.
 
As used in these Notes to Condensed Consolidated
 
Financial Statements,
the term Legacy Quaker refers to the Company prior
 
to the closing of its combination with Houghton International,
 
Inc. (“Houghton”)
(herein referred to as the “Combination”).
 
The condensed consolidated financial statements included herein
 
are unaudited and have
been prepared in accordance with generally accepted
 
accounting principles in the United States (“U.S. GAAP”) for
 
interim financial
reporting and the United States Securities and Exchange Commission
 
(“SEC”) regulations.
 
Certain information and footnote
disclosures normally included in financial statements prepared
 
in accordance with U.S. GAAP have been condensed or
 
omitted
pursuant to such rules and regulations.
 
In the opinion of management, the financial statements reflect all
 
adjustments which are
necessary for a fair statement of the financial position,
 
results of operations and cash flows for the interim periods.
 
The results for the
three months ended March 31, 2021 are not necessarily
 
indicative of the results to be expected for the full year.
 
These financial
statements should be read in conjunction with the Company’s
 
Annual Report filed on Form 10-K for the year
 
ended December 31,
2020 (the “2020 Form 10-K”).
 
Description of Business
The Company was organized in 1918, incorporated
 
as a Pennsylvania business corporation in 1930, and in August
 
2019
completed the Combination with Houghton to form
 
Quaker Houghton.
 
Quaker Houghton is a global leader in industrial process
fluids.
 
With a presence around the world,
 
including operations in over
25
 
countries, the Company’s customers
 
include thousands of
the world’s most advanced
 
and specialized steel, aluminum, automotive, aerospace,
 
offshore, can, mining, and metalworking
companies.
 
Quaker Houghton develops, produces, and markets a broad range
 
of formulated chemical specialty products and offers
chemical management services (which the Company refers
 
to as “Fluidcare”) for various heavy industrial and manufacturing
applications throughout its
four
 
segments: Americas; Europe, Middle East and Africa (“EMEA”);
 
Asia/Pacific; and Global Specialty
Businesses.
Hyper-inflationary economies
 
Based on various indices or index compilations being
 
used to monitor inflation in Argentina as well as economic
 
instability,
effective July 1, 2018, Argentina’s
 
economy was considered hyper-inflationary under U.S.
 
GAAP.
 
As a result, the Company began
applying hyper-inflationary accounting with respect
 
to the Company's wholly owned Argentine
 
subsidiary beginning July 1, 2018.
 
In
addition, Houghton has an Argentina
 
subsidiary to which hyper-inflationary accounting also is applied.
 
As of, and for the three
months ended March 31, 2021, the Company's Argentine
 
subsidiaries represented less than
1
% of the Company’s consolidated
 
total
assets and net sales, respectively.
 
During the three months ended March 31, 2021 and 2020,
 
the Company recorded $
0.2
 
million and
$
0.1
 
million, respectively, of
 
remeasurement losses associated with the applicable currency conversions
 
related to Argentina.
 
These
losses were recorded within foreign exchange (losses) gains,
 
net, which is a component of other income (expense),
 
net, in the
Company’s Condensed
 
Consolidated Statements of Operations.
COVID-19
Management continues to monitor the impact that the COVID-19
 
pandemic is having on the Company,
 
the overall specialty
chemical industry,
 
and the economies and markets in which the Company operates.
 
The full extent of the COVID-19 pandemic
related business and travel restrictions and changes to
 
business and consumer behavior intended to reduce its spread are
 
uncertain as of
the date of this Quarterly Report on Form 10-Q for the
 
period ended March 31, 2021 (the “Report”) as COVID-19
 
and the responses
of governmental authorities continue to evolve globally.
Further, management continues to
 
evaluate how COVID-19-related circumstances, such as remote
 
work arrangements, affect
financial reporting processes, internal control over financial
 
reporting, and disclosure controls and procedures.
 
While the
circumstances have presented and are expected to continue
 
to present challenges, at this time, Management does not believe that
COVID-19 has had a material impact on financial reporting
 
processes, internal control over financial reporting,
 
and disclosure
controls and procedures.
The Company cannot reasonably estimate the magnitude
 
of the effects these conditions will have on the Company’s
 
operations in
the future as they are subject to significant uncertainties
 
relating to the ultimate geographic spread of the virus,
 
the incidence and
severity of the symptoms, the duration or resurgence
 
of the outbreak, the global availability and acceptance of vaccines
 
as well as their
efficacy,
 
the length of the travel restrictions and business
 
closures imposed by governments of impacted countries,
 
and the economic
response by governments of impacted countries.
To the extent
 
that the Company’s customers and
 
suppliers continue to be significantly and adversely impacted by
 
COVID-19, this
could reduce the availability,
 
or result in delays, of materials or supplies to or from
 
the Company, which in
 
turn could significantly
interrupt the Company’s
 
business operations.
 
Such impacts could grow and become more significant to the
 
Company’s operations
and the Company’s liquidity
 
or financial position.
 
Therefore, given the speed and frequency of continuously
 
evolving developments
with respect to this pandemic, the Company cannot reasonably
 
estimate the magnitude or the full extent to which COVID-19
 
may
impact the Company’s results
 
of operations, liquidity or financial position.